
  
    
      
        Introduction_NNP
        Elastase-induced_NNP emphysema_NN in_IN rodents_NNS is_VBZ the_DT most_RBS widely_RB
        studied_VBN animal_NN model_NN for_IN human_JJ emphysema_NN ._. Several_JJ
        alterations_NNS in_IN diaphragmatic_JJ structure_NN and_CC function_NN have_VBP
        been_VBN demonstrated_VBN in_IN this_DT model_NN ._. Among_IN these_DT are_VBP diaphragm_NN
        fiber_NN shortening_VBG with_IN a_DT corresponding_JJ shift_NN in_IN the_DT
        length-tension_JJ curve_NN [_NN 1_CD 2_CD 3_CD 4_CD 5_CD ]_NN and_CC variable_JJ changes_NNS in_IN
        the_DT contractile_NN properties_NNS of_IN diaphragm_NN strips_NNS 
        in_IN vitro_NN [_NN 2_CD 3_CD 5_CD 6_CD ]_NN ._. Increased_VBN
        fatigue_NN resistance_NN of_IN the_DT muscle_NN is_VBZ the_DT single_JJ alteration_NN
        in_IN contractile_NN properties_NNS that_WDT has_VBZ been_VBN most_RBS consistently_RB [_NN
        2_CD 3_CD 6_CD ]_NN ,_, though_IN not_RB always_RB [_NN 7_CD ]_NN ,_, identified_VBN ._. This_DT
        fatigue_NN resistance_NN has_VBZ been_VBN accompanied_VBN by_IN an_DT increased_VBN
        oxidative_JJ capacity_NN in_IN the_DT diaphragmatic_JJ muscle_NN fibers_NNS as_IN
        demonstrated_VBN by_IN increased_VBN activities_NNS of_IN citrate_NN synthase_NN [_NN
        7_CD 8_CD ]_NN and_CC succinate_NN dehydrogenase_NN (_( SDH_NNP )_) [_NN 2_CD 3_CD ]_NN ._.
        In_IN contrast_NN ,_, fiber_NN type_NN has_VBZ generally_RB not_RB been_VBN found_VBN to_TO
        be_VB significantly_RB altered_VBN in_IN the_DT diaphragms_NNS of_IN emphysematous_JJ
        animals_NNS [_NN 1_CD 2_CD 3_CD 8_CD ]_NN ,_, although_IN in_IN all_DT reports_NNS addressing_VBG
        this_DT issue_NN the_DT fibers_NNS were_VBD typed_VBN histochemically_RB rather_RB
        than_IN by_IN myosin_NN heavy_JJ chain_NN (_( MHC_NNP )_) composition_NN ._. Furthermore_RB ,_,
        the_DT kinetics_NNS of_IN diaphragmatic_JJ muscle_NN contraction_NN that_IN one_PRP
        would_MD expect_VB to_TO result_VB from_IN shifts_NNS in_IN fiber_NN type_NN
        distribution_NN ,_, such_JJ as_IN time_NN to_TO peak_VB tension_NN ,_, have_VBP also_RB
        generally_RB [_NN 2_CD 3_CD 6_CD 9_CD ]_NN ,_, but_CC not_RB always_RB [_NN 7_CD ]_NN ,_, been_VBN found_VBN
        to_TO be_VB unaltered_JJ in_IN emphysema_NN ._. A_DT change_NN in_IN fiber_NN type_NN
        distribution_NN in_IN the_DT diaphragm_NN of_IN emphysematous_JJ hamsters_NNS was_VBD
        shown_VBN for_IN the_DT first_JJ time_NN recently_RB [_NN 10_CD ]_NN ,_, but_CC again_RB
        histochemical_JJ classification_NN was_VBD employed_VBN ,_, and_CC no_DT
        corresponding_JJ change_NN in_IN twitch_VB kinetics_NNS was_VBD demonstrated_VBN ._.
        In_IN the_DT scalene_NN muscle_NN ,_, an_DT accessory_JJ muscle_NN of_IN inspiration_NN ,_,
        of_IN emphysematous_JJ hamsters_NNS ,_, an_DT increase_NN in_IN IIa_NNP fibers_NNS and_CC a_DT
        decrease_NN in_IN IIx_NNP fibers_NNS has_VBZ been_VBN demonstrated_VBN with_IN the_DT use_NN
        of_IN anti-_NN MHC_NNP monoclonal_NN antibodies_NNS ._. There_EX was_VBD no_DT difference_NN ,_,
        however_RB ,_, in_IN contractile_NN properties_NNS between_IN emphysema_NN and_CC
        control_NN muscle_NN in_IN that_DT study_NN [_NN 11_CD ]_NN ._.
        In_IN humans_NNS ,_, our_PRP$ group_NN and_CC one_CD other_JJ have_VBP demonstrated_VBN
        marked_VBN alterations_NNS in_IN MHC_NNP expression_NN in_IN the_DT diaphragm_NN in_IN
        severe_JJ emphysema_NN [_NN 12_CD 13_CD ]_NN ._. This_DT shift_NN toward_IN slow_JJ MHC_NNP
        isoforms_NNS has_VBZ been_VBN proposed_VBN to_TO subserve_NN an_DT adaptive_JJ
        resistance_NN to_TO fatigue_NN in_IN the_DT human_JJ diaphragm_NN in_IN emphysema_NN
        which_WDT is_VBZ similar_JJ to_TO that_DT seen_VBN in_IN the_DT animal_NN model_NN ._.
        Although_IN most_JJS of_IN the_DT experimental_JJ work_NN on_IN adaptation_NN of_IN
        the_DT diaphragm_NN to_TO emphysema_NN has_VBZ been_VBN performed_VBN in_IN hamsters_NNS ,_,
        rats_NNS also_RB develop_VBP significant_JJ and_CC often_RB marked_VBD increases_NNS in_IN
        lung_NN volumes_NNS and_CC compliance_NN ,_, and_CC reductions_NNS in_IN expiratory_NN
        flows_NNS ,_, after_IN intratracheal_NN administration_NN of_IN elastase_NN [_NN 14_CD
        15_CD 16_CD 17_CD 18_CD ]_NN ._. MHC_NNP adaptation_NN in_IN emphysematous_JJ rat_NN
        diaphragm_NN has_VBZ not_RB been_VBN studied_VBN systematically_RB ._. Because_IN
        monoclonal_NN MHC_NNP antibodies_NNS are_VBP better_RBR characterized_VBN in_IN rat_NN
        than_IN hamster_NN ,_, and_CC with_IN the_DT availability_NN of_IN a_DT
        semi-quantitative_JJ reverse_NN transcriptase_NN polymerase_NN chain_NN
        reaction_NN (_( RT-PCR_NNP )_) assay_NN for_IN rat_NN MHC_NNP mRNA_NN [_NN 19_CD ]_NN ,_, we_PRP set_VBD
        out_IN to_TO study_VB changes_NNS in_IN MHC-determined_NNP fiber_NN types_NNS and_CC MHC_NNP
        mRNA_NN expression_NN in_IN emphysematous_JJ rat_NN diaphragm_NN ._. To_TO evaluate_VB
        whether_IN shifts_NNS toward_IN more_RBR energy-efficient_JJ isoforms_NNS of_IN the_DT
        second_JJ most_RBS important_JJ ATPase_NNP in_IN muscle_NN might_MD also_RB occur_VB in_IN
        emphysematous_JJ diaphragm_NN ,_, we_PRP also_RB studied_VBD changes_NNS in_IN
        sarcoplasmic_JJ /_NN endoplasmic-reticulum_JJ Ca_MD 2_CD +_NN -_: ATPase_NNP (_( SERCA_NNP )_)
        expression_NN ._.
        Further_RB ,_, we_PRP sought_VBD to_TO correlate_VBP changes_NNS in_IN MHC_NNP and_CC SERCA_NNP
        expression_NN with_IN the_DT physiologic_JJ function_NN of_IN diaphragm_NN
        strips_NNS 
        in_IN vitro_NN ._. We_PRP hypothesized_VBN that_IN we_PRP
        would_MD identify_VB significant_JJ alterations_NNS in_IN MHC_NNP (_( and_CC perhaps_RB
        SERCA_NNP )_) expression_NN in_IN the_DT emphysematous_JJ rat_NN diaphragm_NN
        similar_JJ to_TO those_DT identified_VBN in_IN humans_NNS with_IN severe_JJ
        emphysema_NN ,_, and_CC that_IN these_DT changes_NNS would_MD be_VB accompanied_VBN by_IN
        corresponding_JJ changes_NNS in_IN contractile_NN properties_NNS ._. It_PRP was_VBD
        expected_VBN that_IN such_JJ findings_NNS might_MD identify_VB the_DT rat_NN model_NN of_IN
        elastase-induced_JJ emphysema_NN as_IN a_DT model_NN in_IN which_WDT the_DT
        diaphragmatic_JJ MHC_NNP changes_NNS that_WDT have_VBP been_VBN shown_VBN to_TO result_VB
        from_IN emphysema_NN in_IN humans_NNS might_MD be_VB explored_JJ further_RB ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Induction_NNP of_IN emphysema_NN
          Eleven_CD 3_CD -_: month-old_JJ Sprague-_NNP Dawley_NNP rats_NNS underwent_VBD
          emphysema_NN induction_NN by_IN a_DT single_JJ intratracheal_NN
          instillation_NN of_IN porcine_NN pancreatic_JJ elastase_NN (_( ICN_NNP
          Biochemicals_NNP ,_, Cleveland_NNP ,_, Ohio_NNP )_) at_IN 25_CD units_NNS per_IN 100_CD g_SYM body_NN
          weight_NN ,_, diluted_VBN in_IN 0_CD ._. 60_CD ml_NN of_IN normal_JJ saline_NN as_IN described_VBN
          previously_RB [_NN 4_CD ]_NN ._. Two_CD animals_NNS died_VBD on_IN the_DT night_NN after_IN
          instillation_NN ,_, with_IN evidence_NN at_IN autopsy_NN the_DT following_VBG day_NN
          of_IN diffuse_NN pulmonary_JJ hemorrhage_NN ._.
          Eleven_CD control_NN animals_NNS were_VBD instilled_JJ with_IN an_DT equal_JJ
          volume_NN of_IN saline_NN without_IN a_DT mortality_NN ._.
          Animals_NNS were_VBD maintained_VBN two_CD per_IN cage_NN with_IN feeding_NN 
          ad_NN libitum_NN for_IN 10_CD months_NNS ._. The_DT
          protocol_NN was_VBD approved_VBN by_IN the_DT Animal_NNP Care_NNP Committees_NNS of_IN
          the_DT Philadelphia_NNP Veterans_NNP Affairs_NNPS Medical_NNP Center_NNP and_CC the_DT
          University_NNP of_IN Pennsylvania_NNP ._.
        
        
          Diaphragm_NNP strip_NN physiology_NN in_IN vitro_NN
          An_DT apparatus_NN for_IN the_DT study_NN 
          in_IN vitro_NN of_IN muscle_NN contractile_NN
          characteristics_NNS similar_JJ to_TO that_DT described_VBD previously_RB [_NN 20_CD
          ]_NN was_VBD assembled_VBN ._. Thirteen-month-old_NNP rats_NNS (_( 10_CD months_NNS after_IN
          the_DT induction_NN of_IN emphysema_NN )_) were_VBD killed_VBN by_IN CO_NNP 
          2_CD inhalation_NN and_CC the_DT diaphragm_NN was_VBD
          quickly_RB harvested_VBN en_IN bloc_NN with_IN the_DT ribcage_NN intact_JJ and_CC
          immersed_VBN in_IN oxygenated_JJ Ringer_NNP 's_POS solution_NN buffered_JJ to_TO pH_NN
          7_CD ._. 4_CD with_IN 10_CD mM_NN 4_CD -_: (_( 2_CD -_: hydroxyethyl_NN )_) -_: 1_CD -_: piperazine_NN
          ethanesulphonic_JJ acid_NN ._. A_DT muscle_NN strip_NN approximately_RB 7_CD ._. 5_CD mm_NN
          in_IN width_NN ,_, including_VBG central_JJ tendon_NN and_CC rib_NN attachments_NNS ,_,
          was_VBD dissected_VBN out_IN under_IN magnification_NN ;_: care_NN was_VBD taken_VBN to_TO
          cut_VB parallel_JJ to_TO the_DT muscle_NN fibers_NNS ._.
          Each_DT strip_NN was_VBD mounted_VBN horizontally_RB in_IN a_DT bath_NN of_IN
          continuously_RB circulating_VBG ,_, oxygenated_JJ solution_NN at_IN 23_CD ±_NN
          1_CD °_NN C_NNP ._. One_CD end_NN of_IN the_DT strip_NN was_VBD tied_VBN to_TO a_DT fixed_VBN post_NN with_IN
          sutures_NNS taken_VBN through_IN the_DT attached_VBN ribs_NNS ._. The_DT central_JJ
          tendon_NN at_IN the_DT other_JJ end_NN was_VBD fixed_VBN to_TO the_DT arm_NN of_IN a_DT
          servomotor_NN system_NN (_( motor_NN model_NN 6450_CD ,_, electronics_NNS model_NN
          300_CD B_NNP ;_: Cambridge_NNP Technology_NNP ,_, Watertown_NNP ,_, Massachusetts_NNP )_) on_IN
          a_DT movable_JJ platform_NN with_IN a_DT single_JJ tie_NN ._. Platinum_NN electrodes_NNS
          (_( each_DT 7_CD mm_NN ×_NN 25_CD mm_NN )_) were_VBD placed_VBN within_IN 1_CD mm_NN of_IN the_DT muscle_NN
          strip_NN on_IN either_DT side_NN ._. The_DT muscles_NNS were_VBD stimulated_VBN with_IN a_DT
          Grass_NNP S_NNP 44_CD stimulator_NN (_( Grass_NNP Instruments_NNP ,_, Quincy_NNP ,_,
          Massachusetts_NNP )_) with_IN pulses_NNS 1_CD ._. 5_CD times_NNS above_IN those_DT needed_VBN
          to_TO achieve_VB maximal_NN twitch_VB force_NN (_( 120_CD V_NNP ,_, 5_CD ms_NNS pulses_NNS )_) ._. A_DT
          series_NN of_IN twitches_NNS generated_VBD every_DT 5_CD seconds_NNS at_IN
          incrementally_RB different_JJ muscle_NN lengths_NNS was_VBD used_VBN to_TO
          identify_VB the_DT point_NN of_IN maximal_NN force_NN generation_NN (_( 
          L_NNP 
          o_NN )_) ._. Mean_VB muscle_NN length_NN at_IN 
          L_NNP 
          o_NN was_VBD 2_CD ._. 68_CD ±_NN 0_CD ._. 09_CD cm_NN in_IN control_NN
          animals_NNS and_CC 2_CD ._. 21_CD ±_NN 0_CD ._. 07_CD cm_NN in_IN animals_NNS with_IN emphysema_NN (_( 
          P_NN =_SYM 0_CD ._. 001_CD )_) ._.
          A_DT length-tension_JJ curve_NN was_VBD generated_VBN from_IN the_DT mean_NN of_IN
          five_CD twitches_NNS at_IN each_DT muscle_NN length_NN between_IN 70_CD %_NN and_CC 120_CD %_NN
          of_IN the_DT previously_RB determined_VBN 
          L_NNP 
          o_NN ._. Fatiguing_NNP characteristics_NNS were_VBD
          then_RB determined_VBN by_IN repeated_VBN stimulation_NN at_IN 100_CD Hz_NNP for_IN 200_CD
          ms_NNS bursts_NNS ,_, and_CC 90_CD trains_NNS /_NN min_NN ._. Muscle_NNP length_NN (_( servomotor_NN
          position_NN )_) ,_, stimulator_NN pulse_NN timing_NN ,_, and_CC data_NNS collection_NN
          were_VBD under_IN computer_NN control_NN with_IN custom_NN software_NN
          developed_VBN in_IN our_PRP$ laboratory_NN ._. A_DT Pentium_NNP computer_NN with_IN a_DT
          data_NNS acquisition_NN board_NN (_( DT_NNP 21_CD -_: EZ_NNP ;_: Data_NNP Translation_NN ,_,
          Marlboro_NNP ,_, Massachusetts_NNP )_) controlled_VBD the_DT experiment_NN and_CC
          recorded_VBD all_DT data_NNS to_TO disk_NN for_IN later_RB analysis_NN ._.
          After_IN study_NN ,_, the_DT strip_NN was_VBD removed_VBN from_IN the_DT apparatus_NN ,_,
          trimmed_VBD of_IN nonmuscle_NN tissue_NN ,_, blotted_JJ dry_JJ ,_, and_CC weighed_VBD ._.
          Total_JJ muscle_NN strip_NN cross-sectional_JJ area_NN was_VBD calculated_VBN as_IN
          wet_JJ muscle_NN mass_NN divided_VBN by_IN muscle_NN length_NN times_NNS density_NN
          (_( taken_VBN to_TO be_VB 1_CD ._. 06_CD g_SYM /_NN cm_NN 3_CD [_NN 21_CD ]_NN )_) ._. Tension_NNP was_VBD calculated_VBN
          by_IN dividing_VBG developed_VBN force_NN by_IN the_DT calculated_VBN
          cross-sectional_JJ area_NN ._. Study_NNP of_IN two_CD of_IN the_DT control_NN rat_NN
          strips_NNS suffered_VBD technical_JJ failure_NN ,_, leaving_VBG nine_CD
          emphysematous_JJ and_CC nine_CD control_NN animals_NNS fully_RB studied_VBN ._.
          Mean_VB strip_NN wet_JJ weight_NN was_VBD 0_CD ._. 092_CD ±_NN 0_CD ._. 004_CD g_SYM in_IN the_DT control_NN
          rats_NNS and_CC 0_CD ._. 088_CD ±_NN 0_CD ._. 003_CD g_SYM in_IN the_DT emphysematous_JJ rats_NNS (_( 
          P_NN =_SYM 0_CD ._. 51_CD )_) ._.
        
        
          Lung_NNP volume_NN determination_NN
          After_IN we_PRP had_VBD dissected_VBN out_RP the_DT diaphragm_NN strips_NNS for_IN
          the_DT physiologic_JJ studies_NNS described_VBD above_IN ,_, the_DT animals_NNS '_POS
          lungs_NNS were_VBD excised_VBN with_IN trachea_NN intact_JJ ._. The_DT trachea_NN was_VBD
          cannulated_JJ with_IN a_DT 16_CD g_SYM intravenous_JJ catheter_NN (_( Angiocath_NNP ;_:
          Becton_NNP Dickinson_NNP ,_, Sandy_NNP ,_, Utah_NNP )_) ,_, an_DT airtight_NN seal_NN was_VBD
          established_VBN ,_, and_CC the_DT lung_NN was_VBD inflated_VBN to_TO a_DT distending_VBG
          pressure_NN of_IN 25_CD cmH_NN 
          2_CD O_NNP ._. This_DT volume_NN (_( at_IN the_DT total_JJ lung_NN
          capacity_NN )_) was_VBD then_RB measured_VBN by_IN water_NN displacement_NN ._.
        
        
          MHC_NNP RT-PCR_NNP
          MHC_NNP mRNA_NN expression_NN was_VBD analyzed_VBN by_IN an_DT MHC_NNP RT-PCR_NNP
          assay_NN as_IN described_VBN initially_RB [_NN 19_CD ]_NN and_CC later_RB adapted_VBN by_IN
          its_PRP$ originators_NNS [_NN 22_CD ]_NN ._. The_DT assay_NN is_VBZ semi-quantitative_JJ ,_,
          permitting_VBG accurate_JJ determination_NN of_IN relative_JJ amounts_NNS of_IN
          mRNA_NN of_IN the_DT embryonic_JJ ,_, neonatal_NN ,_, I_PRP ,_, IIa_NNP ,_, IIx_NNP ,_, and_CC IIb_NNP MHC_NNP
          isoforms_NNS in_IN muscle_NN ._. The_DT assay_NN 's_POS accuracy_NN has_VBZ been_VBN
          confirmed_VBN against_IN Northern_NNP blot_NN analysis_NN [_NN 19_CD ]_NN ._.
          In_IN brief_JJ ,_, mRNA_NN was_VBD extracted_VBN from_IN an_DT approximately_RB 50_CD
          mg_NN fragment_NN of_IN frozen_VBN diaphragm_NN taken_VBN from_IN the_DT central_JJ
          portion_NN of_IN the_DT strip_NN used_VBN in_IN the_DT physiologic_JJ experiments_NNS
          described_VBD above_IN ._. This_DT was_VBD done_VBN with_IN the_DT Micro-fast_NNP Track_NNP
          2_CD ._. 0_CD Kit_NNP (_( Invitrogen_NNP ,_, Carlsbad_NNP ,_, California_NNP )_) in_IN accordance_NN
          with_IN the_DT manufacturer_NN 's_POS protocol_NN ._. The_DT mRNA_NN was_VBD then_RB
          suspended_VBN in_IN 20_CD μl_NN of_IN elution_NN buffer_NN and_CC the_DT
          concentration_NN was_VBD determined_VBN by_IN measuring_VBG the_DT attenuance_NN
          at_IN a_DT wavelength_NN of_IN 260_CD nm_NN ._. mRNA_NN (_( 150_CD ng_NN )_) was_VBD reverse_VB
          transcribed_JJ for_IN each_DT muscle_NN sample_NN with_IN the_DT First-strand_NNP
          cDNA_NN Synthesis_NNP Kit_NNP (_( Amersham_NNP Pharmacia_NNP ,_, Piscataway_NNP ,_, New_NNP
          Jersey_NNP )_) ,_, and_CC the_DT cDNA_NN product_NN was_VBD then_RB used_VBN in_IN the_DT
          PCR_NNP ._.
          The_DT PCR_NNP (_( Fig_NNP ._. 1_LS )_) involved_VBN six_CD reaction_NN tubes_NNS for_IN each_DT
          muscle_NN sample_NN ,_, one_CD tube_NN for_IN each_DT isoform_NN studied_VBN ._. A_DT
          single_JJ 5_CD '_POS oligonucleotide_NN common_JJ primer_NN ,_, designed_VBN from_IN a_DT
          highly_RB conserved_JJ region_NN in_IN all_DT known_VBN rat_NN MHC_NNP genes_NNS
          approximately_RB 500_CD base_NN pairs_NNS upstream_RB of_IN the_DT stop_NN codon_NN ,_,
          was_VBD used_VBN in_IN every_DT reaction_NN tube_NN (_( sequence_NN
          5_CD '_POS -_: AGAAGGAGCAGGACACCAGC-_NNP 3_CD '_POS )_) ._. A_DT different_JJ 3_CD '_POS
          oligonucleotide_NN primer_NN ,_, designed_VBN from_IN a_DT divergent_JJ portion_NN
          of_IN the_DT 3_CD '_POS -_: untranslated_JJ region_NN of_IN each_DT of_IN the_DT different_JJ
          MHC_NNP genes_NNS ,_, was_VBD used_VBN in_IN each_DT reaction_NN tube_NN to_TO provide_VB
          isoform_NN specificity_NN (_( sequences_NNS in_IN [_NN 19_CD 22_CD ]_NN )_) ._. Template_NNP ,_,
          in_IN addition_NN to_TO 5_CD μg_NN of_IN reverse_NN transcribed_JJ cDNA_NN ,_, included_VBD
          1_CD pg_NN of_IN an_DT internal_JJ control_NN fragment_NN [_NN 22_CD ]_NN to_TO be_VB
          coamplified_JJ with_IN each_DT PCR_NNP by_IN using_VBG the_DT same_JJ primers_NNS and_CC
          target_NN sequences_NNS ._. However_RB ,_, this_DT control_NN template_NN yields_VBZ a_DT
          fragment_NN of_IN different_JJ size_NN from_IN that_DT resulting_VBG from_IN
          amplification_NN of_IN the_DT MHC_NNP genes_NNS in_IN each_DT tube_NN [_NN 22_CD ]_NN (_( Fig_NNP ._.
          1_LS )_) ,_, and_CC permits_VBZ controlling_VBG for_IN the_DT efficiency_NN of_IN each_DT
          PCR_NNP amplification_NN ._.
          The_DT PCR_NNP was_VBD performed_VBN in_IN a_DT 50_CD μl_NN total_JJ reaction_NN
          volume_NN ._. This_DT mixture_NN contained_VBD the_DT two_CD templates_NNS
          described_VBD above_IN ,_, 5_CD μl_NN of_IN 10_CD ×_NN PCR_NNP buffer_NN (_( Promega_NNP )_) ,_, 4_CD μl_NN
          of_IN 25_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD μl_NN dNTP_NN ,_, 1_CD μM_NN of_IN each_DT of_IN the_DT two_CD
          appropriate_JJ primers_NNS ,_, and_CC 0_CD ._. 5_CD units_NNS of_IN DNA_NNP 
          Taq_NNP polymerase_NN (_( Promega_NNP )_) ,_, with_IN
          water_NN to_TO bring_VB it_PRP to_TO final_JJ volume_NN ._. Amplifications_NNP were_VBD
          performed_VBN in_IN a_DT thermal_JJ cycler_NN with_IN an_DT initial_JJ denaturing_VBG
          step_NN of_IN 5_CD minutes_NNS at_IN 96_CD °_NN C_NNP ,_, followed_VBN by_IN 25_CD cycles_NNS ,_, with_IN
          each_DT cycle_NN consisting_VBG of_IN 1_CD minute_NN at_IN 96_CD °_NN C_NNP ,_, 50_CD seconds_NNS at_IN
          60_CD °_NN C_NNP ,_, 50_CD seconds_NNS at_IN 70_CD °_NN C_NNP ,_, and_CC a_DT final_JJ step_NN of_IN 3_CD minutes_NNS
          at_IN 72_CD °_NN C_NNP ._. The_DT number_NN of_IN cycles_NNS was_VBD optimized_JJ so_IN that_IN the_DT
          amplified_VBN signal_NN was_VBD on_IN the_DT linear_JJ portion_NN of_IN a_DT
          semilogarithmic_JJ plot_NN of_IN the_DT yield_NN expressed_VBN as_IN a_DT function_NN
          of_IN the_DT number_NN of_IN cycles_NNS ._. The_DT PCR_NNP products_NNS were_VBD separated_JJ
          on_IN 2_CD ._. 0_CD %_NN agarose_NN gels_NNS and_CC stained_JJ with_IN ethidium_NN bromide_NN
          (_( Fig_NNP ._. 1_LS )_) ._.
          Negative_JJ images_NNS of_IN the_DT gels_NNS were_VBD produced_VBN under_IN
          ultraviolet_NN light_JJ with_IN Polaroid_NNP film_NN type_NN 665_CD ,_, ISO_NNP 80_CD /_NN 20_CD ,_,
          positive_JJ /_NN negative_JJ ,_, black_NN and_CC white_JJ (_( Polaroid_NNP ,_, Bedford_NNP ,_,
          Massachusetts_NNP )_) ._. Densitometry_NNP of_IN the_DT bands_NNS was_VBD performed_VBN
          on_IN the_DT negatives_NNS (_( Personal_NNP Densitometer_NNP ;_: Molecular_NNP
          Dynamics_NNP ,_, Sunnyvale_NNP ,_, California_NNP )_) with_IN Image_NN Quant_NN
          software_NN 's_POS '_POS area_NN quantitation_NN '_'' paradigm_NN ._. To_TO correct_VB for_IN
          any_DT differences_NNS in_IN the_DT efficiency_NN of_IN the_DT reactions_NNS for_IN
          each_DT isoform_NN ,_, the_DT intensity_NN of_IN the_DT MHC_NNP band_NN was_VBD divided_VBN
          by_IN the_DT intensity_NN of_IN the_DT control_NN fragment_NN in_IN that_DT
          reaction_NN ._. A_DT correction_NN factor_NN was_VBD calculated_VBN for_IN each_DT
          band_NN on_IN the_DT basis_NN of_IN its_PRP$ size_NN ,_, to_TO normalize_VB the_DT intensity_NN
          of_IN the_DT staining_VBG for_IN the_DT different_JJ sizes_NNS of_IN the_DT fragments_NNS ._.
          The_DT final_JJ percentage_NN content_NN of_IN each_DT MHC_NNP gene_NN in_IN the_DT
          total_JJ sample_NN was_VBD then_RB calculated_VBN from_IN the_DT fraction_NN of_IN a_DT
          specific_JJ corrected_VBN value_NN relative_JJ to_TO the_DT sum_NN of_IN expressed_VBD
          MHC_NNP mRNA_NN isoforms_NNS in_IN a_DT given_VBN sample_NN [_NN 19_CD ]_NN ._. We_PRP performed_VBD
          the_DT reverse_JJ transcription_NN and_CC the_DT PCR_NNP in_IN triplicate_NN for_IN
          each_DT piece_NN of_IN muscle_NN ,_, starting_VBG with_IN the_DT same_JJ mRNA_NN sample_NN ._.
          The_DT final_JJ value_NN represents_VBZ the_DT mean_NN of_IN these_DT three_CD
          runs_NNS ._.
        
        
          MHC_NNP immunocytochemistry_NN
          Fiber_NNP types_NNS were_VBD determined_VBN by_IN indirect_JJ
          immunofluorescence_NN on_IN serial_NN frozen_VBN cross_NN sections_NNS of_IN rat_NN
          diaphragm_NN with_IN monoclonal_NN antibodies_NNS specific_JJ for_IN the_DT
          following_JJ MHCs_NNP :_: NOQ_NNP 7_CD ._. 5_LS ._. 4_CD D_NNP for_IN type_NN I_PRP [_NN 23_CD ]_NN ,_, SC-_NNP 71_CD for_IN
          type_NN IIa_NNP [_NN 24_CD ]_NN ,_, and_CC BF-F_NNP 3_CD for_IN type_NN IIb_NNP [_NN 24_CD ]_NN ._. The_DT
          antibody_NN useful_JJ for_IN the_DT identification_NN of_IN type_NN IIx_NNP
          fibers_NNS ,_, BF-_NNP 35_CD [_NN 24_CD ]_NN ,_, stains_NNS all_DT fibers_NNS except_IN pure_JJ IIx_NNP
          fibers_NNS ._. To_TO aid_VB in_IN the_DT visualization_NN of_IN the_DT periphery_NN of_IN
          the_DT fibers_NNS ,_, we_PRP simultaneously_RB co-incubated_JJ each_DT section_NN
          with_IN a_DT rabbit_NN anti-rat_JJ laminin_NN primary_JJ antibody_NN (_( Sigma_NNP ,_,
          St_NNP Louis_NNP ,_, Missouri_NNP )_) at_IN a_DT dilution_NN of_IN 1_CD :_: 2500_CD ,_, followed_VBN by_IN
          a_DT fluorescein-conjugated_JJ sheep_NN anti-rabbit_JJ IgG_NNP secondary_JJ
          antibody_NN ._. Our_PRP$ tissue_NN preparation_NN and_CC staining_VBG protocols_NNS
          for_IN the_DT type_NN I_PRP and_CC IIa_NNP antibodies_NNS have_VBP been_VBN described_VBN
          previously_RB [_NN 20_CD 25_CD ]_NN ,_, with_IN the_DT modification_NN that_IN
          NOQ_NNP 7_CD ._. 5_LS ._. 4_CD D_NNP was_VBD used_VBN at_IN 1_CD :_: 500_CD dilution_NN ,_, the_DT section_NN was_VBD
          incubated_JJ with_IN each_DT of_IN these_DT primary_JJ antibodies_NNS for_IN 18_CD
          hours_NNS at_IN 4_CD °_NN C_NNP ,_, and_CC rhodamine-conjugated_JJ secondary_JJ
          antibodies_NNS were_VBD used_VBN ._. For_IN BF-F_NNP 3_CD we_PRP used_VBD a_DT primary_JJ
          antibody_NN dilution_NN of_IN 1_CD :_: 50_CD ,_, an_DT 18_CD hour_NN incubation_NN ,_, and_CC a_DT
          donkey_NN anti-mouse_JJ IgM_NNP rhodamine-conjugated_JJ secondary_JJ
          antibody_NN ._. For_IN BF-_NNP 35_CD we_PRP used_VBD a_DT primary_JJ antibody_NN dilution_NN
          of_IN 1_CD :_: 10_CD ,_, a_DT 24_CD hour_NN incubation_NN ,_, and_CC a_DT goat_NN anti-mouse_JJ IgG_NNP
          rhodamine-conjugated_JJ secondary_JJ antibody_NN ._.
          Fibers_NNP were_VBD classified_VBN on_IN the_DT basis_NN of_IN the_DT antibody_NN
          that_WDT yielded_VBD the_DT strongest_JJS fluorescent_NN staining_VBG (_( or_CC the_DT
          absence_NN of_IN staining_VBG with_IN BF-_NNP 35_CD for_IN pure_JJ IIx_NNP fibers_NNS )_) ._.
          Thus_RB ,_, we_PRP did_VBD not_RB assess_VB the_DT proportions_NNS of_IN fibers_NNS that_WDT
          might_MD have_VB coexpressed_JJ more_JJR than_IN one_CD MHC_NNP ._. Subjectively_NNP ,_,
          we_PRP saw_VBD no_DT evidence_NN of_IN coexpression_NN of_IN fiber_NN types_NNS I_PRP and_CC
          IIa_NNP ,_, but_CC owing_VBG to_TO the_DT nature_NN of_IN antibody_NN BF-_NNP 35_CD ,_, which_WDT
          stains_NNS all_DT except_IN pure_JJ IIx_NNP fibers_NNS ,_, we_PRP are_VBP unable_JJ to_TO rule_VB
          out_RP the_DT coexpression_NN of_IN IIx_NNP with_IN any_DT other_JJ isoform_NN ._. There_EX
          were_VBD very_RB rare_JJ fibers_NNS (_( less_JJR than_IN 1_CD %_NN )_) that_IN stained_JJ only_RB
          lightly_RB with_IN BF-F_NNP 3_CD and_CC did_VBD not_RB stain_VB with_IN BF-_NNP 35_CD ._. We_PRP
          interpreted_VBD these_DT as_RB probably_RB representing_VBG intermediate_JJ
          fibers_NNS expressing_VBG both_DT IIb_NNP and_CC IIx_NNP ._. We_PRP did_VBD not_RB count_VB
          these_DT fibers_NNS toward_IN the_DT totals_NNS reported_VBD in_IN the_DT results_NNS
          section_NN ._.
          At_IN least_JJS 500_CD fibers_NNS were_VBD evaluated_VBN for_IN each_DT specimen_NN
          in_IN determining_VBG the_DT percentage_NN of_IN each_DT MHC-determined_NNP
          fiber_NN type_NN ._. Using_VBG software_NN that_WDT had_VBD been_VBN custom-designed_JJ
          in_IN our_PRP$ laboratory_NN we_PRP also_RB determined_VBD the_DT percentage_NN of_IN
          the_DT total_JJ surface_NN area_NN of_IN each_DT cross_NN section_NN of_IN muscle_NN
          occupied_VBN by_IN each_DT MHC-determined_NNP fiber_NN type_NN ._.
        
        
          SERCA_NNP immunocytochemistry_NN
          Mouse_NNP IgG_NNP monoclonal_NN antibodies_NNS directed_VBN against_IN the_DT
          slow_JJ and_CC fast_RB isoforms_NNS of_IN SERCA_NNP ,_, respectively_RB ,_, were_VBD also_RB
          used_VBN on_IN serial_NN sections_NNS of_IN rat_NN diaphragm_NN (_( catalogue_NN
          numbers_NNS MA_NNP 3_CD -_: 91_CD and_CC MA_NNP 3_CD -_: 911_CD ;_: Affinity_NNP BioReagents_NNP ,_, Inc_NNP ._. ,_,
          Golden_NNP ,_, Colorado_NNP )_) ._. Each_DT section_NN was_VBD preincubated_JJ with_IN 2_CD %_NN
          bovine_JJ serum_NN albumin_NN for_IN 1_CD hour_NN ,_, then_RB incubated_JJ overnight_JJ
          at_IN 4_CD °_NN C_NNP with_IN the_DT appropriate_JJ primary_JJ antibody_NN at_IN 1_CD :_: 500_CD
          dilution_NN ._. A_DT goat_NN anti-mouse_JJ IgG_NNP secondary_JJ antibody_NN
          conjugated_JJ to_TO Cy_NNP 3_CD was_VBD used_VBN at_IN 1_CD :_: 200_CD dilution_NN for_IN 1_CD hour_NN ,_,
          regardless_RB of_IN which_WDT primary_JJ antibody_NN was_VBD used_VBN ._.
        
        
          Statistical_NNP analysis_NN
          Data_NNP are_VBP reported_VBN as_IN means_VBZ ±_NN SE_NNP ._. We_PRP used_VBD a_DT
          repeated-measures_JJ analysis_NN of_IN variance_NN with_IN a_DT Huynh-_NNP Feldt_NNP
          correction_NN to_TO compare_VB emphysematous_JJ and_CC control_NN groups_NNS
          with_IN respect_NN to_TO MHC_NNP transcript_NN levels_NNS by_IN PCR_NNP and_CC
          MHC-determined_NNP fiber-type_JJ number_NN by_IN immunocytochemistry_NN ._.
          We_PRP noted_VBD a_DT group-by-type_JJ interaction_NN and_CC then_RB performed_VBN 
          t_NN -_: tests_NNS to_TO compare_VB the_DT two_CD groups_NNS
          with_IN respect_NN to_TO each_DT of_IN the_DT MHC_NNP isoforms_NNS ._. Fatigue_NNP data_NNS
          were_VBD analyzed_VBN by_IN 
          t_NN -_: test_NN comparing_VBG mean_NN values_NNS of_IN
          measured_VBN to_TO initial_JJ force_NN ratio_NN ._. A_DT 
          P_NN value_NN of_IN 0_CD ._. 05_CD or_CC less_JJR was_VBD
          considered_VBN to_TO represent_VB statistical_JJ significance_NN ._.
        
      
      
        Results_NNS
        
          Lung_NNP volume_NN
          We_PRP determined_VBD H_NNP 
          2_CD O_NNP displacement_NN lung_NN volumes_NNS at_IN total_JJ
          lung_NN capacity_NN (_( 25_CD cmH_NN 
          2_CD O_NNP airway_NN pressure_NN )_) as_IN the_DT simplest_JJS
          measure_NN to_TO document_VB the_DT hyperexpansion_NN characteristic_NN of_IN
          emphysema_NN in_IN the_DT elastase-treated_JJ animals_NNS ._. Because_IN there_EX
          was_VBD very_RB little_JJ difference_NN in_IN body_NN mass_NN between_IN control_NN
          and_CC emphysematous_JJ animals_NNS (_( 613_CD ±_NN 15_CD g_SYM control_NN ,_, 
          n_NN =_SYM 11_CD ;_: 629_CD ±_NN 11_CD g_SYM emphysema_NN ,_, 
          n_NN =_SYM 9_CD ;_: 
          P_NN =_SYM 0_CD ._. 42_CD )_) ,_, the_DT differences_NNS in_IN lung_NN
          volume_NN were_VBD highly_RB significant_JJ whether_IN or_CC not_RB they_PRP were_VBD
          normalized_JJ to_TO body_NN mass_NN ._. Crude_JJ lung_NN volumes_NNS were_VBD 34_CD ._. 2_LS ±_NN
          0_CD ._. 6_CD ml_NN in_IN emphysematous_JJ animals_NNS (_( 
          n_NN =_SYM 9_CD )_) and_CC 25_CD ._. 3_LS ±_NN 0_CD ._. 3_CD ml_NN in_IN
          controls_NNS animals_NNS (_( 
          n_NN =_SYM 10_CD )_) (_( 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._. Thus_RB ,_, H_NNP 
          2_CD O_NNP displacement_NN lung_NN volumes_NNS were_VBD
          increased_VBN by_IN 35_CD %_NN in_IN emphysematous_JJ animals_NNS over_IN
          controls_NNS ._.
        
        
          Measurement_NNP of_IN MHC_NNP isoform_NN expression_NN by_IN
          RT-PCR_NNP
          The_DT mean_JJ percentage_NN compositions_NNS of_IN mRNA_NN representing_VBG
          each_DT MHC_NNP isoform_NN in_IN the_DT diaphragms_NNS of_IN emphysematous_JJ and_CC
          control_NN animals_NNS are_VBP listed_VBN in_IN Table_NNP 1_CD ._. Note_VB that_IN there_EX
          was_VBD a_DT significant_JJ decrease_NN in_IN the_DT expression_NN of_IN MHC_NNP IIb_NNP
          in_IN emphysematous_JJ versus_CC control_NN ._. Although_IN the_DT increase_NN in_IN
          the_DT expression_NN of_IN the_DT three_CD slower_JJR adult_NN isoforms_NNS did_VBD not_RB
          reach_VB statistical_JJ significance_NN for_IN any_DT individual_JJ
          isoform_NN ,_, all_DT demonstrated_VBD a_DT trend_NN to_TO greater_JJR expression_NN
          in_IN emphysema_NN ._. This_DT trend_NN was_VBD most_JJS marked_VBN in_IN the_DT IIx_NNP
          isoform_NN ,_, for_IN which_WDT the_DT 
          P_NN value_NN for_IN increased_VBN expression_NN in_IN
          emphysematous_JJ versus_CC control_NN diaphragm_NN reached_VBD 0_CD ._. 06_CD ._.
          Thus_RB ,_, there_EX was_VBD modest_JJ shift_NN toward_IN expression_NN of_IN slower_JJR
          isoforms_NNS at_IN the_DT mRNA_NN level_NN ,_, and_CC this_DT shift_NN occurred_VBD
          predominantly_RB at_IN the_DT faster_JJR end_NN of_IN the_DT MHC_NNP spectrum_NN ._.
        
        
          Measurement_NNP of_IN MHC_NNP isoform_NN expression_NN by_IN
          immunocytochemistry_NN
          Immunocytochemical_NNP results_NNS measuring_VBG MHC_NNP
          protein-determined_JJ fiber_NN type_NN closely_RB mirrorred_JJ the_DT PCR_NNP
          results_NNS at_IN the_DT mRNA_NN level_NN ._. Table_NNP 2_CD demonstrates_VBZ that_IN ,_, as_IN
          determined_VBN by_IN immunocytochemistry_NN ,_, emphysematous_JJ animals_NNS
          had_VBD a_DT significantly_RB lower_JJR percentage_NN of_IN fibers_NNS classified_VBN
          as_IN IIb_NNP and_CC a_DT trend_NN toward_IN increased_VBN numbers_NNS of_IN IIx_NNP and_CC
          slow_JJ fibers_NNS ._. When_WRB calculated_VBN on_IN the_DT basis_NN of_IN area_NN
          occupied_VBN by_IN each_DT fiber_NN type_NN ,_, the_DT difference_NN between_IN
          emphysema_NN and_CC control_NN did_VBD not_RB reach_VB significance_NN even_RB for_IN
          the_DT IIb_NNP antibody_NN (_( 
          P_NN =_SYM 0_CD ._. 06_CD )_) ._. Note_VB that_IN although_IN the_DT
          results_NNS with_IN RT-PCR_NNP and_CC immunocytochemistry_NN are_VBP
          qualitatively_RB similar_JJ ,_, they_PRP are_VBP quantitatively_RB different_JJ ._.
          Figure_NN 2_CD shows_VBZ a_DT typical_JJ panel_NN from_IN serial_NN sections_NNS of_IN one_CD
          of_IN the_DT emphysematous_JJ diaphragm_NN specimens_NNS stained_JJ with_IN
          each_DT of_IN the_DT monoclonal_NN antibodies_NNS ._.
        
        
          SERCA_NNP expression_NN by_IN immunocytochemistry_NN
          There_EX was_VBD no_DT significant_JJ difference_NN in_IN the_DT numbers_NNS of_IN
          fibers_NNS expressing_VBG either_CC SERCA_NNP 1_CD or_CC SERCA_NNP 2_CD between_IN the_DT
          emphysematous_JJ and_CC control_NN groups_NNS ._. For_IN SERCA_NNP 1_CD ,_, 62_CD ._. 4_LS %_NN of_IN
          fibers_NNS were_VBD positive_JJ in_IN controls_NNS and_CC 63_CD ._. 3_LS %_NN in_IN the_DT
          emphysematous_JJ animals_NNS (_( 
          P_NN =_SYM 57_CD )_) ._. For_IN SERCA_NNP 2_CD ,_, 38_CD ._. 9_CD %_NN of_IN
          fibers_NNS were_VBD positive_JJ in_IN each_DT group_NN (_( 
          P_NN =_SYM 0_CD ._. 99_CD )_) ._.
        
        
          In_IN vitrostrip_NN physiology_NN
          The_DT results_NNS of_IN the_DT diaphragm_NN strip_NN physiological_JJ
          studies_NNS are_VBP detailed_JJ in_IN Table_NNP 3_CD ._. It_PRP is_VBZ notable_JJ that_IN the_DT
          physiological_JJ parameters_NNS that_WDT have_VBP previously_RB been_VBN most_RBS
          strongly_RB correlated_JJ with_IN a_DT shift_NN to_TO slower_JJR MHC_NNP isoforms_NNS
          (_( time_NN to_TO peak_VB tension_NN ,_, and_CC fatiguing_VBG characteristics_NNS )_)
          were_VBD significantly_RB altered_VBN in_IN the_DT expected_VBN direction_NN in_IN
          the_DT emphysematous_JJ versus_CC control_NN diaphragm_NN strips_NNS ._. Time_NNP
          to_TO peak_VB tension_NN was_VBD longer_RBR in_IN the_DT emphysematous_JJ group_NN
          with_IN a_DT 
          P_NN value_NN of_IN 0_CD ._. 015_CD ,_, and_CC the_DT
          emphysematous_JJ diaphragm_NN was_VBD less_RBR fatiguable_JJ with_IN a_DT 
          P_NN value_NN of_IN 0_CD ._. 023_CD ._. There_EX was_VBD no_DT
          significant_JJ difference_NN in_IN specific_JJ force_NN generated_VBN or_CC in_IN
          the_DT half_JJ relaxation_NN time_NN ._.
        
      
      
        Discussion_NNP
        To_TO our_PRP$ knowledge_NN ,_, these_DT data_NNS are_VBP the_DT first_JJ report_NN of_IN
        significant_JJ changes_NNS in_IN MHC_NNP expression_NN with_IN corresponding_JJ
        physiologic_JJ alterations_NNS in_IN any_DT respiratory_JJ muscle_NN of_IN an_DT
        animal_NN model_NN of_IN emphysema_NN ._. These_DT changes_NNS are_VBP qualitatively_RB
        similar_JJ to_TO those_DT reported_VBD in_IN severe_JJ human_JJ emphysema_NN [_NN 12_CD 13_CD
        ]_NN :_: that_DT is_VBZ ,_, they_PRP too_RB are_VBP manifested_JJ as_IN a_DT shift_NN toward_IN
        slower_JJR MHC_NNP isoforms_NNS ._. Quantitatively_NNP ,_, however_RB ,_, the_DT changes_NNS
        are_VBP far_RB less_JJR marked_VBD than_IN the_DT shift_NN demonstrated_VBN in_IN
        humans_NNS ._.
        The_DT most_RBS studied_VBN animal_NN model_NN for_IN the_DT adaptation_NN of_IN
        respiratory_JJ muscle_NN to_TO emphysema_NN has_VBZ been_VBN the_DT hamster_NN with_IN
        elastase-induced_JJ emphysema_NN ._. The_DT hamster_NN model_NN has_VBZ probably_RB
        been_VBN chosen_VBN for_IN these_DT studies_NNS in_IN large_JJ part_NN because_IN of_IN the_DT
        impressive_JJ increases_NNS in_IN lung_NN volumes_NNS that_WDT can_MD be_VB created_VBN in_IN
        hamsters_NNS ,_, with_IN total_JJ lung_NN capacity_NN sometimes_RB reaching_VBG 200_CD %_NN
        of_IN control_NN values_NNS ._. Despite_IN the_DT demonstration_NN of_IN length_NN
        adaptation_NN [_NN 1_CD 2_CD 3_CD 4_CD 6_CD ]_NN and_CC fatigue_NN resistance_NN [_NN 2_CD 3_CD 6_CD ]_NN
        in_IN the_DT diaphragms_NNS of_IN emphysematous_JJ hamsters_NNS ,_, not_RB until_IN very_RB
        recently_RB could_MD a_DT change_VB in_IN fiber_NN type_NN distribution_NN be_VB
        demonstrated_VBN [_NN 10_CD ]_NN ,_, and_CC in_IN that_DT study_NN histochemical_JJ
        classification_NN was_VBD employed_VBN that_WDT could_MD not_RB separate_VB out_RP IIx_NNP
        from_IN IIb_NNP fibers_NNS ._. Furthermore_RB ,_, no_DT study_NN in_IN emphysematous_JJ
        hamster_NN diaphragm_NN has_VBZ demonstrated_VBN a_DT change_NN in_IN twitch_VB
        kinetics_NNS ._.
        Intratracheal_NNP instillation_NN of_IN elastase_NN in_IN rats_NNS creates_VBZ a_DT
        form_NN of_IN panacinar_NN emphysema_NN that_IN in_IN some_DT ways_NNS more_RBR closely_RB
        parallels_VBZ the_DT human_JJ disease_NN than_IN that_DT created_VBN by_IN
        instillation_NN of_IN elastase_NN in_IN hamsters_NNS ._. Changes_NNS in_IN lung_NN
        volumes_NNS and_CC compliance_NN in_IN the_DT rat_NN are_VBP more_RBR similar_JJ to_TO those_DT
        seen_VBN in_IN humans_NNS [_NN 14_CD 15_CD 16_CD 17_CD 18_CD ]_NN ._. An_DT electron_NN microscopic_JJ
        comparison_NN of_IN human_JJ emphysema_NN with_IN elastase-induced_JJ
        emphysema_NN in_IN rats_NNS revealed_VBD remarkably_RB similar_JJ pictures_NNS of_IN
        elastin_NN disintegration_NN accompanied_VBN by_IN increased_VBN collagen_NN
        deposition_NN and_CC reorganization_NN [_NN 26_CD ]_NN ._.
        Our_PRP$ results_NNS for_IN MHC_NNP expression_NN in_IN rat_NN diaphragm_NN from_IN
        normal_JJ and_CC emphysematous_JJ rats_NNS must_MD be_VB viewed_VBN first_JJ in_IN the_DT
        light_NN of_IN previous_JJ quantitative_JJ studies_NNS of_IN MHC_NNP expression_NN in_IN
        normal_JJ rat_NN diaphragm_NN that_WDT used_VBD techniques_NNS able_JJ to_TO separate_VB
        out_RP all_DT known_VBN isoforms_NNS ._. In_IN 7_CD -_: 9_CD -_: week-old_JJ Sprague-_NNP Dawley_NNP
        rats_NNS ,_, Kanbara_NNP 
        et_CC al_NN ._. [_NN 27_CD ]_NN found_VBN by_IN 
        in_IN situ_NN hybridization_NN that_IN 1_CD ._. 0_CD %_NN of_IN
        fibers_NNS expressed_VBD only_RB IIb_NNP and_CC 8_CD ._. 8_CD %_NN coexpressed_JJ the_DT IIx_NNP and_CC
        IIb_NNP isoforms_NNS ._. This_DT is_VBZ in_IN contrast_NN with_IN our_PRP$ RT-PCR_NNP result_NN of_IN
        21_CD ._. 6_CD %_NN IIb_NNP in_IN normals_NNS ,_, but_CC immunocytochemical_JJ results_NNS much_RB
        more_JJR in_IN line_NN with_IN Kanbara_NNP 's_POS findings_NNS ._. In_IN that_DT study_NN ,_, the_DT
        values_NNS for_IN MHCs_NNP I_PRP ,_, IIa_NNP ,_, and_CC IIx_NNP were_VBD not_RB markedly_RB different_JJ
        from_IN those_DT reported_VBN here_RB for_IN normal_JJ rat_NN diaphragm_NN by_IN
        RT-PCR_NNP ._. By_IN electrophoretic_JJ separation_NN ,_, Sugiura_NNP 
        et_CC al_NN ._. [_NN 28_CD ]_NN found_VBD IIb_NNP MHC_NNP to_TO
        represent_VB 6_CD ._. 1_CD %_NN of_IN all_DT MHC_NNP protein_NN in_IN young_JJ rat_NN diaphragm_NN ,_,
        and_CC their_PRP$ IId_NNP /_NN IIx_NNP result_NN of_IN 44_CD ._. 9_CD %_NN is_VBZ also_RB quite_RB different_JJ
        from_IN our_PRP$ PCR_NNP result_NN ,_, while_IN their_PRP$ I_PRP and_CC IIa_NNP findings_NNS are_VBP
        very_RB similar_JJ to_TO our_PRP$ PCR_NNP results_NNS ,_, and_CC their_PRP$ IId_NNP /_NN IIx_NNP result_NN
        closely_RB parallels_VBZ our_PRP$ IIx_NNP area_NN percentage_NN
        immunocytochemistry_NN result_NN ._. Okumoto_NNP 
        et_CC al_NN ._. reported_VBD even_RB less_JJR IIb_NNP and_CC
        more_JJR IId_NNP protein_NN by_IN electrophoresis_NNS in_IN 5_CD -_: month-old_JJ rats_NNS [_NN
        29_CD ]_NN ._.
        The_DT differences_NNS between_IN the_DT findings_NNS of_IN these_DT reports_NNS
        and_CC ours_PRP might_MD at_IN first_JJ glance_NN result_NN from_IN the_DT age_NN of_IN the_DT
        animals_NNS studied_VBN ,_, as_IN our_PRP$ rats_NNS were_VBD significantly_RB older_JJR at_IN 13_CD
        months_NNS ._. However_RB ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN there_EX is_VBZ an_DT
        age-related_JJ transition_NN from_IN fast_RB to_TO slow_VB MHC_NNP in_IN rat_NN limb_NN
        muscles_NNS [_NN 30_CD 31_CD ]_NN and_CC diaphragm_NN [_NN 32_CD ]_NN ,_, which_WDT would_MD render_VB
        this_DT explanation_NN unlikely_JJ ._. A_DT potential_JJ explanation_NN of_IN our_PRP$
        results_NNS in_IN relation_NN to_TO Kanbara_NNP 's_POS would_MD be_VB that_IN there_EX was_VBD a_DT
        systematically_RB greater_JJR concentration_NN of_IN IIb_NNP mRNA_NN in_IN IIb_NNP and_CC
        IIb_NNP /_NN IIx_NNP fibers_NNS than_IN of_IN other_JJ isoforms_NNS '_POS mRNAs_NNS in_IN their_PRP$
        respective_JJ fibers_NNS ._. Sugiura_NNP 
        et_CC al_NN ._. and_CC Okumoto_NNP 
        et_CC al_NN ._. used_VBN Wistar_NNP rats_NNS ,_, although_IN
        this_DT would_MD be_VB unlikely_JJ to_TO explain_VB the_DT difference_NN between_IN
        their_PRP$ findings_NNS and_CC ours_PRP ._. In_IN the_DT final_JJ analysis_NN ,_, it_PRP is_VBZ
        difficult_JJ to_TO draw_VB any_DT firm_NN conclusions_NNS from_IN comparisons_NNS
        between_IN studies_NNS addressing_VBG mRNA_NN levels_NNS and_CC those_DT addressing_VBG
        protein_NN levels_NNS ;_: and_CC similarly_RB between_IN techniques_NNS measuring_VBG
        protein_NN by_IN gel_NN and_CC those_DT measuring_VBG protein_NN by_IN
        immunocytochemistry_NN ._.
        Although_IN increased_VBN activities_NNS of_IN citrate_NN synthase_NN [_NN 7_CD ]_NN
        and_CC SDH_NNP [_NN 2_CD 3_CD ]_NN have_VBP usually_RB been_VBN demonstrated_VBN in_IN the_DT
        diaphragm_NN in_IN animal_NN models_NNS of_IN emphysema_NN ,_, fiber_NN type_NN has_VBZ
        generally_RB not_RB been_VBN found_VBN to_TO be_VB significantly_RB altered_VBN [_NN 1_CD 2_CD
        3_CD 7_CD ]_NN ._. Only_RB in_IN one_CD recent_JJ paper_NN was_VBD a_DT shift_NN in_IN MHC_NNP in_IN
        emphysematous_JJ diaphragm_NN demonstrated_VBD ,_, but_CC the_DT histochemical_JJ
        technique_NN used_VBN precluded_VBN the_DT separation_NN of_IN IIb_NNP and_CC IIx_NNP
        fibers_NNS [_NN 10_CD ]_NN ._. Another_DT study_NN has_VBZ shown_VBN increased_VBN
        expression_NN of_IN IIa_NNP at_IN the_DT expense_NN of_IN IIx_NNP MHC_NNP in_IN
        emphysematous_JJ hamster_NN scalene_NN muscle_NN with_IN the_DT use_NN of_IN MHC_NNP
        monoclonal_NN antibodies_NNS ,_, but_CC there_EX were_VBD none_NN of_IN the_DT expected_VBN
        physiologic_JJ changes_NNS accompanying_VBG the_DT shift_NN [_NN 11_CD ]_NN ._.
        We_PRP demonstrate_VBP here_RB a_DT shift_NN from_IN IIb_NNP toward_IN IIx_NNP in_IN
        emphysematous_JJ rat_NN diaphragm_NN at_IN both_DT the_DT protein_NN and_CC mRNA_NN
        levels_NNS ._. Although_IN this_DT shift_NN toward_IN a_DT slower_JJR isoform_NN is_VBZ not_RB
        as_RB marked_VBN as_IN that_DT reported_VBD in_IN humans_NNS [_NN 12_CD 13_CD ]_NN ,_, in_IN which_WDT
        MHC_NNP type_NN I_PRP is_VBZ upregulated_JJ and_CC both_DT IIa_NNP and_CC IIx_NNP are_VBP
        downregulated_JJ ,_, there_EX is_VBZ precedent_NN for_IN restricted_VBN MHC_NNP
        adaptation_NN in_IN rats_NNS ._. Termin_NNP 
        et_CC al_NN ._. [_NN 33_CD ]_NN for_IN example_NN ,_, have_VBP noted_VBN
        that_IN whereas_IN chronically_RB stimulated_VBN rabbit_NN fast-twitch_JJ
        muscle_NN results_NNS in_IN appreciable_JJ increases_NNS in_IN slow_JJ myosin_NN
        isoforms_NNS ,_, chronic_JJ stimulation_NN of_IN rat_NN muscle_NN tends_VBZ to_TO bring_VB
        about_IN shifts_NNS toward_IN the_DT slower_JJR types_NNS among_IN the_DT type_NN II_NNP
        isoforms_NNS ._. Other_JJ factors_NNS that_WDT might_MD lead_VB to_TO less_RBR impressive_JJ
        MHC_NNP shifts_NNS in_IN rodent_NN models_NNS of_IN emphysema_NN than_IN in_IN humans_NNS
        include_VBP the_DT much_RB shorter_JJR time_NN course_NN over_IN which_WDT the_DT
        adaptations_NNS have_VBP a_DT chance_NN to_TO occur_VB ,_, the_DT greater_JJR compliance_NN
        of_IN the_DT rodent_NN thorax_NN to_TO pulmonary_JJ hyperexpansion_NN ,_, and_CC
        differences_NNS in_IN the_DT diaphragmatic_JJ load_NN created_VBN in_IN the_DT human_JJ
        disease_NN in_IN comparison_NN with_IN the_DT animal_NN models_NNS that_WDT have_VBP yet_RB
        to_TO be_VB fully_RB worked_VBN out_RP ._.
        Our_PRP$ finding_VBG in_IN the_DT diaphragms_NNS of_IN rats_NNS with_IN emphysema_NN is_VBZ
        very_RB similar_JJ to_TO that_DT demonstrated_VBN by_IN Sugiura_NNP 
        et_CC al_NN ._. in_IN the_DT diaphragms_NNS of_IN
        chronically_RB swimming_VBG rats_NNS [_NN 28_CD ]_NN ._. We_PRP found_VBD IIb_NNP mRNA_NN
        expression_NN to_TO decrease_VB by_IN 31_CD %_NN and_CC IIb_NNP MHC-determined_NNP fiber_NN
        type_NN to_TO decrease_VB by_IN 35_CD %_NN in_IN emphysema_NN ._. Sugiura_NNP 
        et_CC al_NN ._. found_VBD that_IN after_IN 10_CD weeks_NNS of_IN
        endurance_NN swimming_NN ,_, IIb_NNP protein_NN from_IN costal_NN diaphragm_NN of_IN
        rats_NNS fell_VBN by_IN 54_CD %_NN ,_, also_RB without_IN statistically_RB significant_JJ
        changes_NNS in_IN the_DT amounts_NNS of_IN other_JJ MHC_NNP isoforms_NNS ._. This_DT suggests_VBZ
        that_IN the_DT effects_NNS of_IN emphysema_NN on_IN the_DT diaphragm_NN are_VBP ,_, as_IN has_VBZ
        been_VBN suggested_VBN by_IN others_NNS ,_, at_IN least_JJS in_IN part_NN a_DT function_NN of_IN
        increased_VBN workload_NN ._.
        Other_JJ studies_NNS of_IN MHC_NNP adaptation_NN in_IN animal_NN models_NNS of_IN
        increased_VBN diaphragmatic_JJ work_NN have_VBP had_VBN conflicting_JJ results_NNS ._.
        Although_IN various_JJ treadmill-running_JJ protocols_NNS have_VBP shown_VBN
        increases_NNS in_IN the_DT aerobic_JJ capacity_NN of_IN the_DT rat_NN diaphragm_NN [_NN 32_CD
        34_CD 35_CD 36_CD 37_CD ]_NN ,_, running_NN has_VBZ generally_RB not_RB been_VBN demonstrated_VBN
        to_TO cause_VB consistent_JJ changes_NNS in_IN the_DT relative_JJ expression_NN of_IN
        MHC_NNP isoforms_NNS [_NN 29_CD 38_CD ]_NN ._. Although_IN one_CD paper_NN has_VBZ shown_VBN a_DT
        decrease_NN in_IN type_NN IIb_NNP fibers_NNS and_CC an_DT increase_NN in_IN type_NN I_PRP
        fibers_NNS [_NN 38_CD ]_NN ,_, and_CC another_DT has_VBZ shown_VBN only_RB a_DT significant_JJ
        decrease_NN in_IN type_NN IIb_NNP fibers_NNS [_NN 39_CD ]_NN ,_, a_DT third_JJ paper_NN reported_VBD
        a_DT surprising_JJ increase_NN in_IN type_NN IIb_NNP fibers_NNS [_NN 40_CD ]_NN ._.
        In_IN contrast_NN ,_, inspiratory_NN resistive_JJ loading_NN by_IN tracheal_NN
        narrowing_NN has_VBZ consistently_RB shown_VBN increases_NNS in_IN the_DT
        percentage_NN of_IN type_NN I_PRP fibers_NNS and_CC the_DT corresponding_JJ MHC_NNP
        isoform_NN in_IN the_DT diaphragm_NN [_NN 41_CD 42_CD 43_CD ]_NN ,_, closely_RB resembling_VBG
        the_DT changes_NNS seen_VBN in_IN severe_JJ human_JJ emphysema_NN ._. Respiratory_JJ
        loading_NN by_IN chronic_JJ hypercapnea_NN has_VBZ also_RB demonstrated_VBN
        similar_JJ changes_NNS [_NN 44_CD ]_NN ._.
        Given_VBN these_DT findings_NNS ,_, one_PRP can_MD postulate_NN that_IN shifts_NNS
        toward_IN slower_JJR MHC_NNP isoforms_NNS in_IN diaphragmatic_JJ muscle_NN fibers_NNS
        result_VBP primarily_RB from_IN some_DT combination_NN of_IN the_DT degree_NN and_CC
        chronicity_NN of_IN the_DT work_NN performed_VBN by_IN the_DT muscle_NN ._. If_IN this_DT is_VBZ
        so_RB ,_, then_RB one_PRP could_MD arrange_VB the_DT experimental_JJ methods_NNS that_WDT
        have_VBP been_VBN explored_JJ that_WDT impose_VB increased_VBN diaphragmatic_JJ
        work_NN ,_, from_IN least_RBS imposed_VBN load_NN to_TO greatest_JJS imposed_VBN load_NN ,_, as_IN
        follows_VBZ :_: running_VBG ,_, swimming_NN ,_, emphysema_NN ,_, hypercapnea_NN ,_,
        tracheal_NN banding_VBG ._. It_PRP is_VBZ possible_JJ that_IN in_IN emphysema_NN ,_, the_DT
        additional_JJ impact_NN on_IN diaphragmatic_JJ physiology_NN of_IN fiber_NN
        shortening_VBG resulting_VBG from_IN pulmonary_JJ hyperexpansion_NN [_NN 1_CD 2_CD 3_CD
        4_CD 5_CD 6_CD ]_NN affects_VBZ MHC_NNP isoform_NN shifts_NNS beyond_IN the_DT influence_NN of_IN
        a_DT pure_JJ increase_NN in_IN the_DT workload_NN on_IN the_DT muscle_NN ._.
        In_IN addition_NN to_TO being_VBG the_DT first_JJ demonstration_NN of_IN a_DT
        decrease_NN in_IN the_DT expression_NN of_IN the_DT IIb_NNP MHC_NNP isoform_NN in_IN an_DT
        animal_NN model_NN of_IN emphysema_NN ,_, this_DT study_NN is_VBZ the_DT first_JJ to_TO
        demonstrate_VB that_IN such_JJ a_DT shift_NN toward_IN slower_JJR isoforms_NNS in_IN
        emphysema_NN has_VBZ a_DT significant_JJ physiologic_JJ impact_NN on_IN
        diaphragmatic_JJ function_NN 
        in_IN vitro_NN ._. We_PRP show_VBP that_IN both_DT twitch_VB
        speed_NN and_CC fatiguing_VBG properties_NNS move_VBP toward_IN slower-twitch_JJ
        characteristics_NNS with_IN this_DT decrease_NN in_IN IIb_NNP expression_NN ._. Given_VBN
        previous_JJ work_NN in_IN this_DT area_NN ,_, it_PRP is_VBZ not_RB unexpected_JJ that_IN even_RB
        a_DT shift_NN only_RB between_IN the_DT fast_JJ isoforms_NNS but_CC away_RB from_IN IIb_NNP
        would_MD result_VB in_IN measurable_JJ physiological_JJ changes_NNS ._. It_PRP has_VBZ
        been_VBN noted_VBN ,_, for_IN example_NN ,_, that_IN IIx_NNP fibers_NNS have_VBP significantly_RB
        higher_JJR SDH_NNP activity_NN than_IN IIb_NNP fibers_NNS [_NN 24_CD 45_CD ]_NN and_CC ,_, further_RBR ,_,
        that_IN IIb_NNP motor_NN units_NNS are_VBP significantly_RB more_JJR fatigue_NN
        sensitive_JJ than_IN IIx_NNP motor_NN units_NNS [_NN 46_CD ]_NN ._. Schiaffino_NNP 
        et_CC al_NN ._. have_VBP also_RB demonstrated_VBN ,_, in_IN rat_NN
        whole_JJ muscles_NNS ,_, a_DT slower_JJR maximum_NN velocity_NN of_IN shortening_VBG in_IN
        muscles_NNS made_VBN up_RP of_IN predominantly_RB IIx_NNP versus_CC IIb_NNP fibers_NNS [_NN 47_CD
        ]_NN ._. Further_RB ,_, Sant_NNP '_POS Ana_NNP Pereira_NNP 
        et_CC al_NN ._. [_NN 48_CD ]_NN have_VBP shown_VBN a_DT major_JJ
        difference_NN in_IN actomyosin_NN ATPase_NNP activity_NN in_IN rat_NN single_JJ IIb_NNP
        and_CC IIx_NNP fibers_NNS ,_, and_CC Sieck_NNP 
        et_CC al_NN ._. [_NN 45_CD ]_NN have_VBP shown_VBN this_DT in_IN
        single_JJ fibers_NNS from_IN rat_NN diaphragm_NN ._.
        Finally_RB ,_, we_PRP examined_VBD the_DT expression_NN of_IN the_DT SERCA_NNP
        proteins_NNS in_IN these_DT animals_NNS ,_, because_IN these_DT proteins_NNS are_VBP
        responsible_JJ for_IN a_DT significant_JJ fraction_NN of_IN energy_NN
        consumption_NN in_IN skeletal_NN muscle_NN ,_, second_JJ only_RB to_TO the_DT energy_NN
        consumed_VBN by_IN the_DT ATPase_NNP responsible_JJ for_IN movement_NN of_IN the_DT
        myosin_NN head_NN ._. Further_RB ,_, diaphragmatic_JJ fatigue_NN might_MD be_VB
        related_VBN to_TO SERCA_NNP function_NN [_NN 49_CD ]_NN and_CC ,_, as_IN discussed_VBN above_IN ,_,
        our_PRP$ emphysematous_JJ animals_NNS showed_VBD decreased_VBN diaphragm_NN strip_NN
        fatigability_NN ._. Previous_JJ work_NN has_VBZ suggested_VBN that_IN although_IN
        SERCA_NNP expression_NN in_IN limb_NN muscles_NNS seems_VBZ to_TO respond_VB to_TO
        increases_NNS in_IN functional_JJ load_NN by_IN upregulating_VBG SERCA_NNP 2_CD (_( the_DT
        slow_JJ SERCA_NNP isoform_NN )_) and_CC downregulating_VBG SERCA_NNP 1_CD (_( the_DT fast_JJ
        isoform_NN )_) [_NN 50_CD ]_NN ,_, similar_JJ responses_NNS might_MD not_RB occur_VB in_IN
        diaphragm_NN [_NN 51_CD ]_NN ._. Our_PRP$ data_NNS showing_VBG no_DT difference_NN in_IN the_DT
        expression_NN of_IN SERCA_NNP 1_CD and_CC SERCA_NNP 2_CD between_IN emphysematous_JJ and_CC
        control_NN animals_NNS are_VBP consistent_JJ with_IN this_DT finding_VBG ._. We_PRP did_VBD
        not_RB measure_VB SERCA_NNP activity_NN or_CC phospholamban_NN
        phosphorylation_NN ._. It_PRP is_VBZ certainly_RB possible_JJ that_IN the_DT overall_JJ
        activities_NNS of_IN one_CD or_CC both_DT of_IN the_DT SERCA_NNP isoforms_NNS are_VBP ,_, in_IN
        fact_NN ,_, different_JJ between_IN emphysematous_JJ and_CC control_NN
        diaphragm_NN ,_, although_IN the_DT numbers_NNS of_IN fibers_NNS expressing_VBG each_DT
        isoform_NN are_VBP not_RB different_JJ ._.
        Because_IN mechanical_JJ indices_NNS of_IN relaxation_NN reflect_VBP the_DT
        function_NN of_IN SERCA_NNP in_IN sequestering_NN calcium_NN in_IN the_DT
        sarcoplasmic_JJ reticulum_NN [_NN 49_CD ]_NN ,_, we_PRP measured_VBD half_JJ relaxation_NN
        times_NNS on_IN our_PRP$ diaphragmatic_JJ strips_NNS ._. It_PRP is_VBZ not_RB surprising_JJ
        that_IN ,_, with_IN no_DT change_NN in_IN SERCA_NNP 1_CD and_CC SERCA_NNP 2_CD expression_NN
        detected_VBN by_IN immunocytochemistry_NN ,_, we_PRP found_VBD no_DT difference_NN in_IN
        the_DT relaxation_NN times_NNS between_IN control_NN and_CC emphysematous_JJ
        diaphragm_NN strips_NNS ._.
      
      
        Conclusion_NNP
        In_IN sum_NN ,_, we_PRP have_VBP demonstrated_VBN a_DT significant_JJ decrease_NN in_IN
        IIb_NNP MHC_NNP expression_NN at_IN both_DT the_DT protein_NN and_CC mRNA_NN levels_NNS in_IN
        the_DT diaphragmatic_JJ muscle_NN of_IN rats_NNS with_IN elastase-induced_JJ
        emphysema_NN ._. In_IN concert_NN with_IN this_DT shift_NN away_RB from_IN the_DT fastest_JJS
        MHC_NNP isoform_NN ,_, we_PRP have_VBP demonstrated_VBN '_POS slower_JJR '_POS physiological_JJ
        characteristics_NNS 
        in_IN vitro_NN ,_, including_VBG a_DT longer_JJR time_NN to_TO
        peak_VB tension_NN and_CC a_DT greater_JJR resistance_NN to_TO fatigue_NN in_IN
        diaphragm_NN strips_NNS ._. These_DT findings_NNS suggest_VBP that_IN earlier_JJR
        reports_NNS of_IN physiological_JJ adaptation_NN within_IN the_DT diaphragm_NN in_IN
        animal_NN models_NNS of_IN emphysema_NN without_IN the_DT demonstration_NN of_IN
        concomitant_NN shifts_NNS in_IN MHC_NNP expression_NN toward_IN slower_JJR isoforms_NNS
        were_VBD limited_VBN by_IN the_DT technologies_NNS then_RB available_JJ ,_, which_WDT did_VBD
        not_RB allow_VB the_DT evaluation_NN of_IN the_DT expression_NN of_IN each_DT of_IN the_DT
        type_NN II_NNP MHC_NNP isoforms_NNS with_IN specific_JJ probes_NNS ._.
        A_DT physiologically_RB significant_JJ shift_NN toward_IN slower_JJR MHC_NNP
        isoforms_NNS does_VBZ occur_VB in_IN elastase-induced_JJ emphysema_NN in_IN
        rodents_NNS as_IN it_PRP does_VBZ in_IN severe_JJ human_JJ emphysema_NN ,_, but_CC in_IN the_DT
        animal_NN model_NN the_DT shift_NN occurs_VBZ at_IN the_DT faster_JJR end_NN of_IN the_DT
        isoform_NN spectrum_NN ,_, primarily_RB between_IN the_DT type_NN II_NNP
        isoforms_NNS ._.
      
      
        Abbreviations_NNP
        MHC_NNP =_SYM myosin_NN heavy_JJ chain_NN ;_: RT-PCR_NNP =_SYM reverse_VB transcriptase_NN
        polymerase_NN chain_NN reaction_NN ;_: SDH_NNP =_SYM succinate_NN dehydrogenase_NN ;_:
        SERCA_NNP =_SYM sarcoplasmic_JJ /_NN endoplasmic-reticulum_JJ Ca_MD
        2_CD +_NN -_: ATPase_NNP ._.
      
    
  
